Skip to main content Accessibility help
×
Home
Hostname: page-component-59b7f5684b-z9m8x Total loading time: 1.508 Render date: 2022-10-01T03:25:44.704Z Has data issue: true Feature Flags: { "shouldUseShareProductTool": true, "shouldUseHypothesis": true, "isUnsiloEnabled": true, "useRatesEcommerce": false, "displayNetworkTab": true, "displayNetworkMapGraph": false, "useSa": true } hasContentIssue true

Section VII - Vulvar Disease

Published online by Cambridge University Press:  20 February 2019

David Chelmow
Affiliation:
Virginia Commonwealth University
Nicole W. Karjane
Affiliation:
Virginia Commonwealth University
Hope A. Ricciotti
Affiliation:
Harvard Medical School
Amy E. Young
Affiliation:
University of Texas, Austin
Get access
Type
Chapter
Information
Office Gynecology
A Case-Based Approach
, pp. 138 - 159
Publisher: Cambridge University Press
Print publication year: 2019

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

References

Kellogg Spadt, S, Kusturiss, E. Vulvar dermatoses: a primer for the sexual medicine clinician. Sex Med Rev 2015;3:126136.CrossRefGoogle ScholarPubMed
American College of Obstetricians and Gynecologists. ACOG Practice Bulletin No. 93: 2008 (reaffirmed 2016).
Bercaw-Pratt, JL, Boardman, LA, Simms-Cendan, JS. Clinical recommendation: pediatric LS. J Pediatr Adolesc Gynecol 2014;27:111116CrossRefGoogle Scholar
Goldstein, AT, Burrows, LJ et al. Safety and efficacy of human fibroblast lysate cream for vulvar LS: a randomized placebo-controlled trial. Acta Derm Venereol 2015;95:847849.Google Scholar
Broddick, B, Belkin, Z, Goldstein, AT. Influence of treatments on prognosis for vulvar LS: facts and controversies. Clin Dermatol 2013;31:780786.CrossRefGoogle Scholar
Davick, JJ, Samuelson, M et al. The prevalence of LS in patients with vulvar squamous cell carcinoma. Int J Gynecol Path 2016;00:15.Google Scholar
Chi, CC, Kirtschig, G, Baldo, M et al. Topical interventions for genital lichen sclerosus.  Cochrane Database Syst Rev. 2011;12:CD008240.Google Scholar
Strittmatter, HJ, Hengge, UR, Blecken, SR. Calcineurin antagonists in vulvar LS. Arch Gynecol Obstet 2006;274:266270.CrossRefGoogle Scholar
Fistarol, SK, Itin, PH. Diagnosis and treatment of LS. Am J Clin Dermatol 2013;14:2747.CrossRefGoogle Scholar
Abramov, Y, Elchalal, et al. Surgical treatment of vulvar LS: a review. Obstet Gynecol Survey 1996;53(3):193199.CrossRefGoogle Scholar

References

Bornstein, J, Bogliatto, F, Haefner, HK et al. Consensus statement: the 2015 International Society for the Study of Vulvovaginal Disease (ISSVD) terminology of vulvar squamous intraepithelial lesions. Obstet Gynecol 2016;127:264268.CrossRefGoogle Scholar
The International Society for the Study of Vulvovaginal Disease: www.issvd.org/ Accessed July 29, 2017.
Bornstein, et al. 2015 ISSVD, ISSWSH and IPPS consensus terminology and classification of persistent vulvar pain and vulvodynia. Obstet Gynecol 2016;127:745751.CrossRefGoogle ScholarPubMed
Lawrie, TA, Nordin, A, Chakrabarti, M et al. Medical and surgical interventions for the treatment of usual-type vulval intraepithelial neoplasia (Review). Cochrane Library, September 2015. Accessed 28 July, 2017.
Committee opinion No 675: management of vulvar intraepithe-lial neoplasia, Obstet Gynecol, October 2016;128(4): e178e182. [See also Committee Opinion No. 675: Management of Vulvar Intraepithelial Neoplasia: Correction, Obstet Gynecol, January 2017;29(1):209.]CrossRef
Thurgar, E, Barton, S, Karner, C, Edwards, SJ. Clinical effectiveness and cost-effectiveness of interventions for the treatment of anogenital warts: systematic review and economic evaluation. Health Technol Assess 2016;20(24).CrossRefGoogle ScholarPubMed
Patel, H, Wagner, M, Singhal, P, Kothari, S. Systematic review of the incidence and prevalence of genital warts. BMC Infect Dis 2013;13:39.CrossRefGoogle ScholarPubMed

References

Friedrich, EG Jr., Vulvar vestibulitis syndrome. J Reprod Med 1987;32:110114.Google ScholarPubMed
Bornstein, J, Goldstein, AT, Stockdale, CK, Bergeron, S et al. 2015 ISSSVD, ISSWSH, and IPPS consensus terminology and classification of persistent vulvar pain and vulvodynia. J Lower Gen Tract Dis 2016;20:126130.CrossRefGoogle ScholarPubMed
Persistent Vulvar Pain. Committee Opinion 673. American College of Obstetricians and Gynecologists. Obstet Gynecol 2016;128:278284.
Reed, BD, Legocki, LJ, Plegue, MA et al. Factors associated with vulvodynia incidence. Obstet Gynecol 2014;123:225232.CrossRefGoogle ScholarPubMed
Chalmers, KJ, Madden, VJ, Hutchinson, MR, Moseley, GL. Local and systemic inflammation in localized, provoked vestibulodynia. A systematic review. Obstet Gynecol 2016;128:337347.CrossRefGoogle ScholarPubMed
Arnold, LD, Bachmann, GA, Rosen, R, Kelly, S, Rhoads, GG. Vulvodynia. characteristics and associations with comorbidities and quality of life. Obstet Gynecol 2006;107:617624.CrossRefGoogle ScholarPubMed
Andrews, JC. Vulvodynia interventions-systematic review and evidence grading. Obstet Gynecol Survey 2011;66:299315.CrossRefGoogle Scholar
De Andres, J, Sanchis-Lopez, N, Asensio-Samper, JM et al. Vulvodynia – an evidenced-based literature review and proposed treatment algorithm. Pain Prac 2016;16:204236.CrossRefGoogle Scholar
Bergeron, S, Khalife, S, Glazer, HI, Binik, YM. Surgical and behavioral treatments for vestibulodynia: two-and-one-half year follow-up and predictors of outcome. Obstet Gynecol 2008;111:159166.CrossRefGoogle ScholarPubMed
Goldfinger, C, Pukall, CF, Gentilcore-Saulnier, E, McLean, L, Chamberlain, S. A prospective study of pelvic floor physical therapy-pain and psychosexual outcomes in provoked vestibulodynia. J Sex Med 2009;6:19551968.CrossRefGoogle ScholarPubMed
Leo, RJ. A systematic review of the utility of anticonvulsant pharmacotherapy in the treatment of vulvodynia pain. J Sex Med 2013;10:20002008.CrossRefGoogle ScholarPubMed
Leo, RJ, Dewani, S. A systematic review of the utility of řantidepressant pharmacotherapy in the treatment of vulvodynia pain. J Sex Med 2013;10:24972505.CrossRefGoogle ScholarPubMed
Murina, F, Bianco, V, Radici, G et al. Transcutaneous electrical nerve stimulation to treat vestibulodynia: a randomized controlled trial. BJOG 2008;115:11651170.CrossRefGoogle Scholar
Kestřánek, J, Špaček, J et al. Radiofrequency therapy for severe idiopathic vulvodynia. J Lower Genit Tract Dis 2013;17: e1e4.CrossRefGoogle ScholarPubMed
Ramsay, LB, Wright, JB, Fischer, JR. Sacral neuromodulation in the treatment of vulvar vestibulitis syndrome. Obstet Gynecol 2009;114:487489.CrossRefGoogle ScholarPubMed

References

Patel, H, Wagner, M, Singhal, P, Kothari, S. Systemic review of the incidence and prevalence of genital warts. BCM Infect Dis 2013;13:39.CrossRefGoogle Scholar
Division of STD Prevention (1999). Prevention of genital HPV infection and sequelae: report of an external consultants’ meeting. Atlanta, GA: Centers for Disease Control and Prevention www.cdc.gov/std/hpv/hpvsupplement99.pdf
Centers for Disease Control and Prevention. 2015 Sexually Transmitted Diseases Treatment Guidelines: Anogenital Warts.
Katz, VL, Lobo, RA, Lentz, GM, Gershenson, DM. Comprehensive gynecology. 5th edn. Philadelphia: Mosby Elsevier. c2007. Chapter 22, General Gynecology: pp. 576–78.Google Scholar
Hoffman, BL, Schorg, JO, Bradshaw, DK et al. eds. Williams Gynecology, 3e New York, NY: McGraw-Hill. 2016. Chapter 3, Gynecologic Infection.Google Scholar
Yanofsky, VR, Patel, RV, Goldenberg, G. Genital warts: a comprehensive review. J Clin Aesthet Dermatol 2012;5:25.Google ScholarPubMed
Sweet, RL, Gibbs, RS. Infectious diseases of the female genital tract. 4th edn. Philadelphia: Lippincott Williams & Wilkins; c2002. Chapter 7, Sexually Transmitted Diseases: pp. 155–65.Google Scholar
Gross, G. Clinical aspects and therapy of anogenital warts and papillomavirus-associated lesions. Hautarzt 2001;52:6.CrossRefGoogle ScholarPubMed
Lacey, CJ, Woodhall, SC, Wikstrom, A, Ross, J. 2012 European guideline for the management of anogenital warts. J Eur Acad Dermatol Venereol 2013;27:e263.CrossRefGoogle ScholarPubMed
Workowski, Ka, Bolan, GA, Centers for Disease Control and Prevention. Sexually transmitted diseases treatment guidelines, 2015. MMWR Recomm Rep 2015;64:1.

References

Sideri, M et al. Topical testosterone in the treatment of vulvar lichen sclerosus. Int J Gynecol Obstet 1994;46:5356.CrossRefGoogle ScholarPubMed
Simonart, T et al. Vulvar lichen sclerosus: effect of maintenance treatment with a moisturizer on the course of the disease. Menopause 2008;15(1):7477.Google ScholarPubMed
Neill, SM et al. Guidelines for the management of lichen sclerosus. Br J Dermatol 2002;147:640649.CrossRefGoogle ScholarPubMed
Paniel, BJ, Rouzier, R. Surgical procedures in benign vulval disease. In: Neill, S, Lewis, F, eds. Ridley’s The Vulva. Wiley-Blackwell. 2009;228234.Google Scholar
Smith, Y, Haefner, H. Vulvar lichen sclerosus: pathophysiology and treatment. Am J Clin Dermatol 2004;5(2):117.CrossRefGoogle ScholarPubMed
Kirtschig, G et al. Evidence-based (S3) guideline on (anogenital) lichen sclerosus. JEADV 2015;29: e1e43.Google ScholarPubMed

References

Pfaller, MA, Diekema, DJ, Gibbs, DL et al. Results from the ARTEMIS DISK Global antifungal surveillance study, 1997 to 2005: an 8.5-year analysis of susceptibilities of candida species and other yeast species to fluconazole and voriconazole determined by CLSI standardized disk diffusion testing. J. Clin. Microbiol 2007;45:17351745.CrossRefGoogle ScholarPubMed
Foxman, B, Muraglia, R, Dietz, JP, Sobel, JD, Wagner, J. Prevalence of recurrent vulvovaginal candidiasis in 5 European countries and the United States: results from an internet panel survey.
Camacho, DP, Consolaro, ME, Patussi, EV et al. Vaginal yeast adherence to the combined contraceptive vaginal ring (CCVR). Contraception 2007 December;76(6):439443.CrossRefGoogle Scholar
2015 STD Treatment guidelines: Diseases characterized by vaginal discharge vulvovaginal candidiasis, Centers for Disease Control and Prevention. www.cdc.gov/std/tg2015/candidiasis.htm Accessed August 2017.
Reed, BD, Zazove, P, Pierson, CL, Gorenflo, DW, Horrocks, J. Candida transmission and sexual behaviors as risks for a repeat episode of candida vulvovaginitis. J Womens Health (Larchmt) 2003;12(10):979.CrossRefGoogle ScholarPubMed
Cerikcioglu, N, Beksac, MS. Cytolytic vaginosis; misdiagnosed as candidal vaginitis. Infect Dis Obstet Gynecol 2004;12:1316.CrossRefGoogle ScholarPubMed
Pappas, PG, Kauffman, CA, Andes, DR et al. Clinical Practice Guideline for the Management of Candidiasis: 2016 Update by the Infectious Diseases Society of America. www.ncbi.nlm.nih.gov/pmc/articles/PMC4725385/ Accessed August 2017.
Vazquez, JA, Sobel, JD, Demitriou, R et al. Karyotyping of Candida albicans isolates obtained longitudinally in women with recurrent vulvovaginal candidiasis. J Infect Dis 1994 Dec;170(6):15661569.CrossRefGoogle ScholarPubMed
Lopez, JEM. Candidiasis (vulvovaginal). Systematic review 815. BMJ Clinical Evidence. http://clinicalevidence.bmj.com/x/systematic-review/0815/overview.html. Accessed August 2017.
Van Kessel, K, Assef, N, Marrazzo J, , Eckert, L. Common complementary and alternative therapies for yeast vaginitis and bacterial vaginosis: a systematic review. Obstet Gynecol Surv. 2003;58(5):351358.CrossRefGoogle ScholarPubMed

References

Wechter, ME, Wu, JM, Marzano, D, Haefner, H. Management of Bartholin duct cysts and abscesses: A systematic review. Obstet Gynecol Surv 2009;64:395404.CrossRefGoogle ScholarPubMed
Kroese, JA, van der Velde, M, Morssink, LP et al. Word catheter and marsupialization in women with a cyst or abscess of the Bartholin gland (WoMan-trial): a randomised clinical trial. BJOG 2017;124:243249.CrossRefGoogle ScholarPubMed
Ozdegirmenci, O, Kayikcioglu, F, Haberal, A. Prospective randomized study of marsupialization versus silver nitrate application in the management of Bartholin gland cysts and abscesses. J Minim Invasive Gynecol 2009;16:149152.CrossRefGoogle ScholarPubMed
Visco, AG, del Priore, G. Postmenopausal Bartholin gland enlargement: A hospital-based cancer risk assessment. Obstet Gynecol 1996;87:286290.CrossRefGoogle ScholarPubMed
Wood, S. Clinical manifestations and therapeutic management of vulvar cellulitis and abscess: methicillin-resistant Staphylococcus aureus, necrotizing fasciitis, Bartholin abscess, Crohn disease of the vulva, hidradenitis suppurativa. Clin Obstet Gynecol 2015;58:503511.CrossRefGoogle ScholarPubMed
Sherer, D, Dalloul, M, Salameh, G, Abulafia, O. Methicillin-resistant Staphylococcus aureus bacteremia and chorioamnionitis after recurrent marsupialization of a Bartholin abscess. Obstet Gynecol 2009;114 (2):471472.CrossRefGoogle ScholarPubMed

Save book to Kindle

To save this book to your Kindle, first ensure coreplatform@cambridge.org is added to your Approved Personal Document E-mail List under your Personal Document Settings on the Manage Your Content and Devices page of your Amazon account. Then enter the ‘name’ part of your Kindle email address below. Find out more about saving to your Kindle.

Note you can select to save to either the @free.kindle.com or @kindle.com variations. ‘@free.kindle.com’ emails are free but can only be saved to your device when it is connected to wi-fi. ‘@kindle.com’ emails can be delivered even when you are not connected to wi-fi, but note that service fees apply.

Find out more about the Kindle Personal Document Service.

Available formats
×

Save book to Dropbox

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Dropbox.

Available formats
×

Save book to Google Drive

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Google Drive.

Available formats
×